A Study of TEPEZZA Subcutaneous Administration in Healthy Adults

NCT06563856 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Bioavailability
Bioequivalence

Interventions

DRUG: TEPEZZA
DRUG: EDP

Sponsor

Amgen